Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Studies long-term symptoms in adults recovering from COVID-19

Observes adults who recovered from COVID-19 to study lasting symptoms after infection.

Plain-language title generated from the registry record
Registry title: Post COVID-19 Condition

Key facts

Where
Düsseldorf, GermanySee the site

Where in Germany

  • University Hospital Heinrich HeineDüsseldorf, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Euresist Network GEIE
Trial code
NCT05531773
Record updated
19 September 2025
Original description
The EuCARE-POSTCOVID study is an observational multicentre study enrolling COVID-19 patients recovered from the acute phase of disease to investigate the prevalence and possible predictors of post COVID-19 condition. The study will retrospectively analyze data already collected at the post COVID-19 outpatients services of the participating centers; furthermore, a prospective cohort study will be performed.Read full original descriptionShow less

Assessment of Post COVID-19 Manifestations in a Multicenter Cohort Study (EuCARE-POSTCOVID Study)

The EuCARE-POSTCOVID study is an observational multicentre study enrolling COVID-19 patients recovered from the acute phase of disease to investigate the prevalence and possible predictors of post COVID-19 condition. The study will retrospectively analyze data already collected at the post COVID-19 outpatients services of the participating centers; furthermore, a prospective cohort study will be performed.

Inclusion: Adult patients, >18 years old; Confirmed diagnosis of COVID-19 disease (positive SARS CoV-2 RNA on naso- pharyngeal swab or upper respiratory sample); Mild COVID-19 disease without hospital admission or moderate/severe disease requiring hospital admission for COVID-19 or hospitalization for other medical issues with a positive SARS CoV-2 RNA sample; Informed consent for the study.

Exclusion: death during hospitalization:; patient's decline to participate in the study.

ClinicalTrials.gov NCT05531773